{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:28:17Z","timestamp":1771928897389,"version":"3.50.1"},"reference-count":71,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009045","name":"Jagiellonian University Medical College","doi-asserted-by":"publisher","award":["N41\/DBS\/000936"],"award-info":[{"award-number":["N41\/DBS\/000936"]}],"id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background and Objectives: Recurrence of lupus nephritis (LN) after kidney transplantation is a major clinical concern in patients with systemic lupus erythematosus (SLE) who progress to end-stage renal disease (ESRD). Reported rates of post-transplant LN recurrence vary widely and are influenced by patient characteristics, immunosuppressive regimens, and indications for allograft biopsy. Patients and Methods: Medical records of adult LN patients treated at the University Hospital in Krak\u00f3w, Poland, during the years 2012\u20132022 were retrospectively reviewed to identify individuals who progressed to ESRD and received a kidney transplant. Data collected included patient demographics as well as clinical, laboratory, transplant-related, and dialysis-related information. Results: Among 1039 patients with SLE, LN was diagnosed in 351 (33.8%), and 28 (8.0%) progressed to ESRD, of whom n = 9 (32.1%) underwent kidney transplantation. All patients received deceased-donor grafts, with a median time from ESRD to transplantation of 3 years (range 1\u20138) and a median post-transplant follow-up of 6 years (3\u201320). Maintenance immunosuppression consisted predominantly of glucocorticosteroids, mycophenolate mofetil, and tacrolimus in 77.8% of patients, with basiliximab induction was used in 2 of 2 patients with available data. Biopsy-proven LN recurrence occurred in 22.2% (2\/9) of recipients. Graft loss was observed in 22.2% (2\/9), while overall mortality reached 33.3% (3\/9), including one peri-transplant death and one death due to infectious complications. Hematological manifestations were present in 100% of patients, hypercholesterolemia in 100%, and arterial hypertension in 88.9%, while anti-dsDNA antibodies were detected in 77.8%. LN relapse occurred despite standard immunosuppressive therapy and in the absence of consistent clinical or immunological predictors. Conclusions: LN recurrence occurred in 2 of 9 patients (22.2%). Patients with LN after kidney transplantation require careful long-term monitoring and individualized immunosuppressive management, considering baseline risk profile and relevant clinical with immunological factors.<\/jats:p>","DOI":"10.3390\/jcm15051682","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:54:56Z","timestamp":1771923296000},"page":"1682","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recurrence and Outcomes of Lupus Nephritis After Renal Transplantation: Analysis of Nine Cases and Review of the Literature"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3913-4457","authenticated-orcid":false,"given":"Magdalena","family":"Morytko","sequence":"first","affiliation":[{"name":"University Hospital in Krak\u00f3w, Clinical Department of Rheumatology, Immunology and Internal Medicine, Jakubowskiego 2, 30-688 Krak\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0321-3557","authenticated-orcid":false,"given":"Rados\u0142aw","family":"Dziedzic","sequence":"additional","affiliation":[{"name":"University Hospital in Krak\u00f3w, Clinical Department of Rheumatology, Immunology and Internal Medicine, Jakubowskiego 2, 30-688 Krak\u00f3w, Poland"},{"name":"Jagiellonian University Medical College, Doctoral School of Medical and Health Sciences, \u015bw. \u0141azarza 16, 31-530 Krak\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1766-1035","authenticated-orcid":false,"given":"Weronika","family":"Pociej-Marciak","sequence":"additional","affiliation":[{"name":"Jagiellonian University Medical College, Division of Ophthalmology and Ocular Oncology, Department of Ophthalmology, Faculty of Medicine, Kopernika 38, 31-501 Krak\u00f3w, Poland"},{"name":"University Hospital in Krak\u00f3w, Department of Ophthalmology and Ocular Oncology, Kopernika 38, 31-501 Krak\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1749-9739","authenticated-orcid":false,"given":"Mariusz","family":"Korkosz","sequence":"additional","affiliation":[{"name":"University Hospital in Krak\u00f3w, Clinical Department of Rheumatology, Immunology and Internal Medicine, Jakubowskiego 2, 30-688 Krak\u00f3w, Poland"},{"name":"Jagiellonian University Medical College, Department of Rheumatology and Immunology, Jakubowskiego 2, 30-688 Krak\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1013-2253","authenticated-orcid":false,"given":"Joanna","family":"Kosa\u0142ka-W\u0119giel","sequence":"additional","affiliation":[{"name":"University Hospital in Krak\u00f3w, Clinical Department of Rheumatology, Immunology and Internal Medicine, Jakubowskiego 2, 30-688 Krak\u00f3w, Poland"},{"name":"Jagiellonian University Medical College, Department of Rheumatology and Immunology, Jakubowskiego 2, 30-688 Krak\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1001\/jama.2024.2315","article-title":"Systemic Lupus Erythematosus: A Review","volume":"331","author":"Siegel","year":"2024","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New Insights into the Immunopathogenesis of Systemic Lupus Erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1177\/0961203320932219","article-title":"Systemic Lupus Erythematosus, Lupus Nephritis and End-Stage Renal Disease: A Pragmatic Review Mapping Disease Severity and Progression","volume":"29","author":"Mahajan","year":"2020","journal-title":"Lupus"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-025-00653-y","article-title":"Lupus Nephritis","volume":"11","author":"Parodis","year":"2025","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00296-024-05579-4","article-title":"Clinical and Laboratory Characteristics of Early-Onset and Delayed-Onset Lupus Nephritis Patients: A Single-Center Retrospective Study","volume":"44","author":"Dziedzic","year":"2024","journal-title":"Rheumatol. Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/art.39594","article-title":"Risk of End-Stage Renal Disease in Patients With Lupus Nephritis, 1971\u20132015: A Systematic Review and Bayesian Meta-Analysis","volume":"68","author":"Tektonidou","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.5500\/wjt.v4.i3.176","article-title":"Kidney Transplantation in Patients with Systemic Lupus Erythematosus","volume":"4","author":"Lionaki","year":"2014","journal-title":"World J. Transplant."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1681\/ASN.2010060656","article-title":"ASN End-Stage Renal Disease Task Force: Perspective on Prospective Payments for Renal Dialysis Facilities","volume":"21","author":"Sedor","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1681\/ASN.2009101093","article-title":"Recurrence of Lupus Nephritis after Kidney Transplantation","volume":"21","author":"Contreras","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/TP.0000000000003136","article-title":"KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation","volume":"104","author":"Chadban","year":"2020","journal-title":"Transplantation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/01.TP.0000053750.59630.83","article-title":"Recurrent Lupus Nephritis in Renal Transplant Recipients Revisited: It Is Not Rare1","volume":"75","author":"Goral","year":"2003","journal-title":"Transplantation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10067-011-1931-y","article-title":"Impact of Recurrent Lupus Nephritis on Lupus Kidney Transplantation: A 20-Year Single Center Experience","volume":"31","author":"Yu","year":"2012","journal-title":"Clin. Rheumatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00005-022-00646-9","article-title":"Treat-to-Target in Lupus Nephritis. What Is the Role of the Repeat Kidney Biopsy?","volume":"70","author":"Parodis","year":"2022","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2023.09.002","article-title":"KDIGO 2024 Clinical Practice Guideline for the Management of LUPUS NEPHRITIS","volume":"105","author":"Rovin","year":"2024","journal-title":"Kidney Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2165\/00003495-200363150-00002","article-title":"Calcineurin Inhibitors in Renal Transplantation: What Is the Best Option?","volume":"63","author":"Tanabe","year":"2003","journal-title":"Drugs"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/annrheumdis-2020-216924","article-title":"2019 Update of the Joint European League Against Rheumatism and European Renal Association\u2013European Dialysis and Transplant Association (EULAR\/ERA\u2013EDTA) Recommendations for the Management of Lupus Nephritis","volume":"79","author":"Fanouriakis","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/annrheumdis-2020-217178","article-title":"Long-Term Outcome of a Randomised Controlled Trial Comparing Tacrolimus with Mycophenolate Mofetil as Induction Therapy for Active Lupus Nephritis","volume":"79","author":"Mok","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.semarthrit.2019.09.009","article-title":"EULAR\/ACR Classification Criteria for SLE","volume":"49","author":"Aringer","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_19","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group (2021). KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int., 100, S1\u2013S276."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/rheumatology\/kel039","article-title":"An Assessment of Renal Failure in an SLE Cohort with Special Reference to Ethnicity, over a 25-Year Period","volume":"45","author":"Adler","year":"2006","journal-title":"Rheumatology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"ar4663","DOI":"10.1186\/ar4663","article-title":"Methodological Quality of Studies of End-Stage Renal Disease Risks in Lupus Nephritis","volume":"16","author":"Tektonidou","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","article-title":"The Frequency and Outcome of Lupus Nephritis: Results from an International Inception Cohort Study","volume":"55","author":"Hanly","year":"2016","journal-title":"Rheumatology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.ekir.2025.01.034","article-title":"Kidney Transplantation Improves Survival in Lupus Nephritis With End-Stage Kidney Disease","volume":"10","author":"Brilland","year":"2025","journal-title":"Kidney Int. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1177\/09612033251352706","article-title":"Clinical and Laboratory Differences in Pediatric-Onset versus Adult-Onset Lupus Nephritis: A Retrospective Cohort Analysis","volume":"34","author":"Dziedzic","year":"2025","journal-title":"Lupus"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.semnephrol.2015.08.011","article-title":"ESKD, Transplantation, and Dialysis in Lupus Nephritis","volume":"35","author":"Sabucedo","year":"2015","journal-title":"Semin. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1093\/ndt\/gfn429","article-title":"Renal Replacement Therapy in Lupus Nephritis","volume":"23","author":"Rietveld","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1136\/ard.2009.122796","article-title":"Recurrent Lupus Nephritis after Kidney Transplantation: A Surveillance Biopsy Study","volume":"69","author":"Norby","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/nep.12657","article-title":"Recurrent Lupus Nephritis after Transplantation: Clinicopathological Evaluation with Protocol Biopsies","volume":"21","author":"Tamer","year":"2016","journal-title":"Nephrology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e15349","DOI":"10.1111\/1756-185X.15349","article-title":"Lupus Flare and Recurrent Lupus Nephritis Following Kidney Transplantation in Patients with Lupus Nephritis","volume":"27","author":"Kim","year":"2024","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_30","first-page":"460","article-title":"Kidney Transplantation in Systemic Lupus Erythematosus: Outcomes and Prognosis","volume":"153","year":"2019","journal-title":"Med. Cl\u00edn. (Engl. Ed.)"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Yang, Y., Yu, B., and Chen, Y. (2015). Blood Disorders Typically Associated with Renal Transplantation. Front. Cell Dev. Biol., 3.","DOI":"10.3389\/fcell.2015.00018"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/1874312901307010087","article-title":"Hematological Disorders in Patients with Systemic Lupus Erythematosus","volume":"7","author":"Bashal","year":"2013","journal-title":"Open Rheumatol. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000442182","article-title":"Sudden Visual Deterioration as the First Symptom of Chronic Kidney Failure","volume":"6","year":"2015","journal-title":"Case Rep. Ophthalmol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.ajkd.2005.01.038","article-title":"The Long-Term Prognosis of Renal Transplantation in Patients With Lupus Nephritis","volume":"45","author":"Moroni","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Dema, B., and Charles, N. (2016). Autoantibodies in SLE: Specificities, Isotypes and Receptors. Antibodies, 5.","DOI":"10.3390\/antib5010002"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Kosa\u0142ka-W\u0119giel, J., Dziedzic, R., Siwiec-Ko\u017alik, A., Spa\u0142kowska, M., Milewski, M., Wach, A., Zar\u0119ba, L., Bazan-Socha, S., and Korkosz, M. (2024). Comparison of Clinical and Laboratory Characteristics in Lupus Nephritis vs. Non-Lupus Nephritis Patients\u2014A Comprehensive Retrospective Analysis Based on 921 Patients. J. Clin. Med., 13.","DOI":"10.3390\/jcm13154486"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.autrev.2009.02.010","article-title":"Latest Update on the Ro\/SS-A Autoantibody System","volume":"8","author":"Fritzler","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"606195","DOI":"10.1155\/2012\/606195","article-title":"Clinical and Pathological Roles of Ro\/SSA Autoantibody System","volume":"2012","author":"Yoshimi","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/ard.62.6.556","article-title":"Anti-dsDNA, Anti-Sm Antibodies, and the Lupus Anticoagulant: Significant Factors Associated with Lupus Nephritis","volume":"62","author":"Alba","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"ref_40","first-page":"1","article-title":"The Frequency of Autoantibodies in Turkish Patients with Lupus Nephritis","volume":"17","author":"Wiik","year":"1997","journal-title":"Rheumatol. Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/rheumatology\/keu343","article-title":"Low Complements and High Titre of Anti-Sm Antibody as Predictors of Histopathologically Proven Silent Lupus Nephritis without Abnormal Urinalysis in Patients with Systemic Lupus Erythematosus","volume":"54","author":"Ishizaki","year":"2015","journal-title":"Rheumatology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archinte.1990.00390160099020","article-title":"Clinical Manifestations of Systemic Lupus Erythematosus: Identification of Racial and Socioeconomic Influences","volume":"150","author":"Ward","year":"1990","journal-title":"Arch. Intern. Med."},{"key":"ref_43","first-page":"541","article-title":"Anti-Neutrophil Cytoplasmic Antibodies in 566 European Patients with Systemic Lupus Erythematosus: Prevalence, Clinical Associations and Correlation with Other Autoantibodies. European Concerted Action on the Immunogenetics of SLE","volume":"16","author":"Galeazzi","year":"1998","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Trivioli, G., Allinovi, M., Di Marcantonio, E., Jawa, N.A., Trivelli, A., Yang, J., Grenda, R., Rubik, J., Mohammad, A.J., and Testa, S. (Clin. J. Am. Soc. Nephrol., 2026). Kidney Transplantation in Childhood-Onset Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: Long-Term Outcomes and Prognostic Factors, Clin. J. Am. Soc. Nephrol., online ahead of print.","DOI":"10.2215\/CJN.0000000936"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/acr.22482","article-title":"Association of Time to Kidney Transplantation With Graft Failure Among US Patients With End-Stage Renal Disease Due to Lupus Nephritis","volume":"67","author":"Plantinga","year":"2015","journal-title":"Arthritis Care Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.transproceed.2013.11.085","article-title":"Influence of Pretransplantation Dialysis Time and Lupus Activity on Outcome of Kidney Transplantation in Systemic Lupus Erythematosus","volume":"46","author":"Chung","year":"2014","journal-title":"Transplant. Proc."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"11611","DOI":"10.1038\/s41598-019-48070-y","article-title":"Outcome and Prognosis of Patients With Lupus Nephritis Submitted to Renal Transplantation","volume":"9","author":"Albuquerque","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1177\/0961203311430220","article-title":"Renal Transplantation in Lupus Nephritis: A Brazilian Cohort","volume":"21","author":"Oliveira","year":"2012","journal-title":"Lupus"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/09612033231219739","article-title":"Referral and Evaluation for Kidney Transplantation among Patients with Lupus Nephritis-Related End-Stage Kidney Disease","volume":"33","author":"McPherson","year":"2024","journal-title":"Lupus"},{"key":"ref_50","first-page":"e20863","article-title":"Relapse and Outcome of Lupus Nephritis After Renal Transplantation in the Modern Immunosuppressive Era","volume":"14","author":"Pattanaik","year":"2022","journal-title":"Cureus"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Khan, M.A., Hanna, A., Sridhara, S., Chaudhari, H., Me, H.M., Attieh, R.M., and Abu Jawdeh, B.G. (2025). Maintenance Immunosuppression in Kidney Transplantation: A Review of the Current Status and Future Directions. J. Clin. Med., 14.","DOI":"10.3390\/jcm14061821"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/art.43212","article-title":"2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis","volume":"77","author":"Sammaritano","year":"2025","journal-title":"Arthritis Rheumatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ard.2025.09.007","article-title":"EULAR Recommendations for the Management of Systemic Lupus Erythematosus with Kidney Involvement: 2025 Update","volume":"85","author":"Fanouriakis","year":"2026","journal-title":"Ann. Rheum. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/ndt\/gfm066","article-title":"Mycophenolate Mofetil in Induction and Maintenance Therapy of Severe Lupus Nephritis: A Meta-Analysis of Randomized Controlled Trials","volume":"22","author":"Zhu","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.kint.2023.09.001","article-title":"Executive Summary of the KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis","volume":"105","author":"Rovin","year":"2024","journal-title":"Kidney Int."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJMra2014530","article-title":"Long-Term Survival after Kidney Transplantation","volume":"385","author":"Hariharan","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Lacave, F., De Terwangne, C., Darius, T., Buemi, A., Mourad, M., France, Y., Cardoso Coelho, J., Fernandes, G., Goffin, E., and Devresse, A. (2024). Basiliximab vs. No Induction Therapy in Kidney Transplant Recipients with a Low Immunological Risk Profile Receiving Tacrolimus\/Mycophenolate\/Steroids Maintenance Immunosuppression. J. Clin. Med., 13.","DOI":"10.3390\/jcm13206151"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1440-1797.2009.01259.x","article-title":"Interleukin-2 Receptor Antibody Does Not Reduce Rejection Risk in Low Immunological Risk or Tacrolimus-Treated Intermediate Immunological Risk Renal Transplant Recipients: IL-2Ra Induction in Kidney Transplant","volume":"15","author":"Lim","year":"2010","journal-title":"Nephrology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1046\/j.1523-1755.2000.00065.x","article-title":"Outcomes of Renal Transplantation among Patients with End-Stage Renal Disease Caused by Lupus Nephritis","volume":"57","author":"Ward","year":"2000","journal-title":"Kidney Int."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2296000","DOI":"10.1080\/0886022X.2023.2296000","article-title":"Graft Survival and Mortality Outcomes after Kidney Transplant in Patients with Lupus Nephritis: A Systematic Review and Meta-Analysis","volume":"46","author":"Jiang","year":"2024","journal-title":"Ren. Fail."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"51","DOI":"10.25100\/cm.v47i1.2085","article-title":"Clinical Outcomes of Kidney Transplants on Patients with End-Stage Renal Disease Secondary to Lupus Nephritis, Polycystic Kidney Disease and Diabetic Nephropathy","volume":"47","year":"2016","journal-title":"Colomb. Medica"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1191\/0961203305lu2067oa","article-title":"Renal Transplantation in Lupus Nephritis","volume":"14","author":"Ponticelli","year":"2005","journal-title":"Lupus"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/ndt\/13.11.2894","article-title":"Renal Transplantation in Systemic Lupus Erythematosus. A Case Control Study of 45 Patients","volume":"13","author":"Azevedo","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"240","DOI":"10.7326\/M18-1570","article-title":"Renal Transplantation and Survival Among Patients with Lupus Nephritis: A Cohort Study","volume":"170","author":"Jorge","year":"2019","journal-title":"Ann. Intern. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1053\/j.ajkd.2021.09.016","article-title":"Incidence of Kidney Replacement Therapy and Subsequent Outcomes Among Patients With Systemic Lupus Erythematosus: Findings From the ERA Registry","volume":"79","author":"Derner","year":"2022","journal-title":"Am. J. Kidney Dis."},{"key":"ref_66","first-page":"e20240061","article-title":"Epidemiological Profile of Kidney Transplant Patients with Lupus Nephritis","volume":"47","author":"Pachi","year":"2025","journal-title":"Braz. J. Nephrol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1177\/09612033241244508","article-title":"Results and Prognosis of Kidney Transplantation in Lupus Nephritis: Experience of an Argentine Center","volume":"33","author":"Ornella","year":"2024","journal-title":"Lupus"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s41100-024-00566-8","article-title":"Complications Associated with Kidney Transplantation, Causes of Graft Failure and Mortality Following Kidney Transplantation in Patients with Systemic Lupus Erythematosus: A Meta-Analysis","volume":"10","author":"Li","year":"2024","journal-title":"Ren. Replace. Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1016\/j.transproceed.2011.08.027","article-title":"11-Year Single-Center Experience in Living-Donor Kidney Transplantation in Poland","volume":"43","author":"Chamienia","year":"2011","journal-title":"Transplant. Proc."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.transproceed.2024.03.027","article-title":"Current Data on Organ Donation and Transplantation in Poland: Poltransplant Activity 2017 to 2022","volume":"56","author":"Pszenny","year":"2024","journal-title":"Transplant. Proc."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1177\/0961203318770527","article-title":"Long-Term Survival of Kidney Grafts in Lupus Nephritis: A Mexican Cohort","volume":"27","author":"Wagner","year":"2018","journal-title":"Lupus"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/5\/1682\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:42:03Z","timestamp":1771926123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/5\/1682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":71,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["jcm15051682"],"URL":"https:\/\/doi.org\/10.3390\/jcm15051682","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]}}}